Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000156609 | SCV000206329 | uncertain significance | not specified | 2014-06-27 | criteria provided, single submitter | clinical testing | The Ile28359Lys variant in TTN has not been previously reported in individuals w ith cardiomyopathy or in large population studies. Computational prediction too ls and conservation analysis do not provide strong support for or against an imp act to the protein. In summary, the clinical significance of the Ile28359Lys var iant is uncertain. |
Gene |
RCV000156609 | SCV000237770 | likely benign | not specified | 2017-11-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001086729 | SCV000765414 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000643727 | SCV001152655 | uncertain significance | not provided | 2018-04-01 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001171250 | SCV001333954 | benign | Cardiomyopathy | 2018-04-12 | criteria provided, single submitter | clinical testing | |
Genetics and Genomics Program, |
RCV001293089 | SCV001434072 | uncertain significance | Primary dilated cardiomyopathy | criteria provided, single submitter | research | ||
Ambry Genetics | RCV002362832 | SCV002664784 | likely benign | Cardiovascular phenotype | 2019-09-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV000156609 | SCV001922264 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000156609 | SCV001928362 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000156609 | SCV001971771 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004724938 | SCV005340026 | likely benign | TTN-related disorder | 2024-09-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |